Nivagen Pharma (India) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-12-2024
- Paid Up Capital ₹ 0.10 M
as on 07-12-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 99.28%
(FY 2022)
- Profit 107.25%
(FY 2022)
- Ebitda 90.02%
(FY 2022)
- Net Worth 132.49%
(FY 2022)
- Total Assets 105.12%
(FY 2022)
About Nivagen Pharma (India)
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pravinchandra Parekh and Jwalant Shukla serve as directors at the Company.
- CIN/LLPIN
U74999MH2018FTC315351
- Company No.
315351
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
05 Oct 2018
- Date of AGM
06 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nivagen Pharma (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pravinchandra Parekh  | Director | 05-Oct-2018 | Current |
Jwalant Shukla  | Director | 05-Oct-2018 | Current |
Financial Performance and Corporate Structure Insights of Nivagen Pharma (India).
Nivagen Pharma (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 99.28% increase. The company also saw a substantial improvement in profitability, with a 107.25% increase in profit. The company's net worth Soared by an impressive increase of 132.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nivagen Pharma (India)?
In 2020, Nivagen Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Circulate Capital Services India Private LimitedActive 3 years 5 monthsPravinchandra Parekh is a mutual person
Gsg Consulting Services Private LimitedActive 12 years 3 monthsPravinchandra Parekh is a mutual person
- Clark Schaefer Hackett Shared Services Private LimitedActive 3 years 1 month
Pravinchandra Parekh is a mutual person
- Edelstein Shared Services Private LimitedActive 1 year 8 months
Pravinchandra Parekh is a mutual person
- Windham Brannon Shared Services Private LimitedActive 1 year 6 days
Pravinchandra Parekh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nivagen Pharma (India)?
Nivagen Pharma (India) has a workforce of 33 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nivagen Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nivagen Pharma (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
